The Effect of Oculo-Motor Exercises in Intermittent Exotropia

Sponsor
Medipol University (Other)
Overall Status
Completed
CT.gov ID
NCT03661476
Collaborator
(none)
51
1
1
4.7
10.9

Study Details

Study Description

Brief Summary

In childhood strabismus, exotropia is most frequently seen with intermittent exotropia and convergence failure in the first decade of life. This situation adversely affects children's psychosocial development and creates worries about personal relationships and work life in their future lives. Patients' hesitant attitudes towards surgical treatment led to the out-of-surgery techniques such as exercise therapy. No studies have been found in the literature on the efficancy of the intermittent exotropia treatments with oculo-motor exercises. In our study, it was aimed to investigate the effects of oculo-motor exercises on intermittent exotropia in children.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Oculo-Motor Exercises (OME)
N/A

Detailed Description

50 volunteer school-aged children between 2-17 years of age) were included in our study. Oculo-motor home exercise protocols were given to all participants for 2 sessions per day for 6 weeks, and regular phone calls were made once a week. Participants were assessed cycloplegic refraction by autorefractometry, corrected and uncorrected visual acuity by snellen chart, ocular motility test, near and distant alternating prism cover test, streopsis test and patient satisfaction levels by intermittent exotropia survery.

Study Design

Study Type:
Interventional
Actual Enrollment :
51 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Investigation of the Effect of Oculo-Motor Exercises in Intermittent Exotropic Children
Actual Study Start Date :
Aug 13, 2018
Actual Primary Completion Date :
Dec 10, 2018
Actual Study Completion Date :
Jan 3, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Oculo-Motor Exercises (OME)

10 repetitive four different oculomotor exercise protocols with eye stabilization were organized as home programs for 6 weeks, twice a day in the morning and evening each day of the week.

Behavioral: Oculo-Motor Exercises (OME)
Oculomotor Exercises (OME); The saccadic eye movement exercise included moving the eyes horizontally between two stationary targets while keeping the head still. The smooth pursuit exercise included moving the target horizontally and tracking it with the eyes while keeping the head still. The adaptation X1 exercise included moving the head horizontally while keeping the stationary target in focus. The adaptation X2 exercise included moving the head and target in opposite directions horizontally while tracking the target with the eyes.

Outcome Measures

Primary Outcome Measures

  1. Prism cover test [6 weeks]

    Near and distant alternating prism cover test

Secondary Outcome Measures

  1. Streopsis test [6 weeks]

    Three-dimensional visual assessment

  2. Intermittent exotropia survery [6 weeks]

    Level of patient satisfaction

  3. Visual acuity [6 weeks]

    Snellen chart

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Be between 2 and 17 years of age

  • Intermittent exotropia diagnosis

  • To have mental capacity in the level to understand and do exercises

Exclusion Criteria:
  • Not complying with age criteria

  • Constant exotropia

  • Having undergone eye surgery

  • Those with systemic disease that prevent exercise

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istanbul Medipol University Istanbul Beykoz Turkey 34810

Sponsors and Collaborators

  • Medipol University

Investigators

  • Study Director: Candan Algun, Faculty of Health Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gülay Aras, PhD PT, Medipol University
ClinicalTrials.gov Identifier:
NCT03661476
Other Study ID Numbers:
  • 10840098-604.01.01-E.34141
First Posted:
Sep 7, 2018
Last Update Posted:
Dec 17, 2019
Last Verified:
Mar 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Gülay Aras, PhD PT, Medipol University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 17, 2019